Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FV041
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $87,555
Award facts
- Contract value 100% obligated
- $87,555.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $87,555.42 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count), with performance in Conshohocken, Pennsylvania and completion targeted for January 21, 2026. This non-competitive delivery order represents a firm fixed-price transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical support vehicle running through December 2026. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support military healthcare operations globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of delivery orders with the DLA Medical Supply Chain. The company's federal contract history demonstrates consistent capability in fulfilling diverse pharmaceutical requirements, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This particular delivery order for Vyndamax—a medication used in the treatment of transthyretin amyloidosis—reflects the company's ongoing role in supporting Defense Health Agency and military healthcare system requirements.
Quick answers
Who was awarded contract SPE2DR26FV041?
SPE2DR26FV041 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FV041 worth?
The government has obligated $87,555 on SPE2DR26FV041.
Is contract SPE2DR26FV041 an order under another contract?
Yes. SPE2DR26FV041 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV041 competed?
The extent of competition for SPE2DR26FV041 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award